moa of semaglutide Oral Semaglutide: A Novel Oral Preparation GLP-1 Receptor Agonist The expanding role of semaglutide:

Having your coffee at least 3060 minutes before or after your injection may help minimise discomfort

The slowed gastric emptying may delay melatonin absorption and alter its effectiveness, with this effect most apparent at the start of treatment or after dose increases

An analysis of electronic health records from over 26,000 adults with obesity and at least one autoimmune disease has shown that those taking GLP-1 medication experienced fewer cardiac events, were less likely to visit the ER, and had a lower risk of death

Adverse Reactions (3% and Greater than Placebo) in WEGOVY-Treated Pediatric Patients Aged 12 Years and Older with Obesity Acute Pancreatitis In WEGOVY clinical trials in adults, acute pancreatitis was confirmed by adjudication in 4 WEGOVY-treated patients (0.2 cases per 100 patient years) versus 1 in placebo-treated patients (less than 0.1 cases per 100 patient years)